Consult physician if pregnant/nursing, taking medication (especially thyroid hormones, anticoagulant medications), or have a medical condition, including thyroid disease
The results of SELECT, which examined the effect of subcutaneous semaglutide injection for the prevention of cardiovascular events in 17,604 patients with obesity (body mass index [BMI] 27 kg/m 2 ) and established cardiovascular disease but without diabetes, were presented in 2023 [25]
No, GLP-1 receptor agonists are not licensed or approved for addiction treatment in the UK
NAION is a severe eye complication that can lead to permanent vision loss
For instance, previous studies performed on resveratrol, curcumin, and quercetin have been shown to suppress the activity of CYP2E1, reducing NAPQI formation, thereby reflecting their hepatoprotective effects (Abbasi-Oshaghi 2019)